Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.38 |
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28064840 | 0.88 | ALDH1A1 (0.44) | ALDH1A1MEN1GAAMAPTHPGD | |
| SCHEMBL28064841 | 0.88 | ALDH1A1 (0.44) | ALDH1A1MEN1GAAMAPTHPGD | |
| SCHEMBL7686914 | 0.88 | HTR7 (0.40) | CHRNA7MTNR1BHTR2C | |
| SCHEMBL7684611 | 0.81 | HTR1A (0.43) | CHRNA7HTR2C | |
| SCHEMBL7677541 | 0.81 | CHRNA7 (0.42) | CHRNA7MTNR1B | |
| SCHEMBL7678362 | 0.79 | SLC6A2 (0.41) | CHRNA7MTNR1BHTR2C | |
| SCHEMBL7678292 | 0.77 | CHRNA7 (0.67) | CHRNA7HTR2C | |
| SCHEMBL7680425 | 0.77 | CHRNA7 (0.67) | CHRNA7HTR2C | |
| SCHEMBL7680070 | 0.77 | CHRNA7 (0.67) | CHRNA7HTR2C | |
| SCHEMBL6002146 | 0.76 | HTR1A (0.45) | HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6417183-B1 | DRUGS RELATES TO 1,4-DIAZACYCLOHEPTANES, TO PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND TO THEIR USE IN METHODS OF THERAPEUTIC TREATMENT OF NERVOUS SYSTEM DISORDERS | ASTRAZENELA UK LIMITED (GB) | 2002-07-09 | — | — | US | disclosed |
| EP-1060169-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES | AstraZeneca AB (SE) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999032461-A1 | 1,4-DIAZACYCLOHEPTANE DERIVATIVES | ASTRAZENECA UK LIMITED (GB) | 1999-07-01 | — | — | WO | disclosed |